CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Debt to Equity Ratio: 0.3735 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3735 |
| September 30, 2023 | 0.3191 |
| June 30, 2023 | 0.9155 |
| March 31, 2023 | 0.9083 |
| December 31, 2022 | 2.496 |
| September 30, 2022 | 1.432 |
| June 30, 2022 | 0.9985 |
| March 31, 2022 | 0.7328 |
| December 31, 2021 | 0.3785 |
| September 30, 2021 | 0.2672 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0253 |
| December 31, 2017 | 0.0718 |
| September 30, 2017 | 0.0787 |
| June 30, 2017 | 3.504 |
| March 31, 2017 | 0.8843 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
2.496
Maximum
Dec 2022
0.4642
Average
0.2672
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Gilead Sciences Inc | 0.00 |
| Assure Holdings Corp | -0.892 |
| Societal CDMO Inc (DELISTED) | 0.6323 |
| AN2 Therapeutics Inc | -- |
| Madrigal Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 434.69M |
| Total Liabilities (Quarterly) | 142.43M |
| Shareholders Equity (Quarterly) | 292.26M |
| Current Ratio | 10.96 |
| Net Debt Paydown Yield | -0.17% |